Biomarkers and Corresponding Biosensors for Childhood Cancer Diagnostics

Abstract

Although tremendous progress has been made in treating childhood cancer, it is still one of the leading causes of death in children worldwide. Because cancer symptoms overlap with those of other diseases, it is difficult to predict a tumor early enough, which causes cancers in children to be more aggressive and progress more rapidly than in adults. Therefore, early and accurate detection methods are urgently needed to effectively treat children with cancer therapy. Identification and detection of cancer biomarkers serve as non-invasive tools for early cancer screening, prevention, and treatment. Biosensors have emerged as a potential technology for rapid, sensitive, and cost-effective biomarker detection and monitoring. In this review, we provide an overview of important biomarkers for several common childhood cancers. Accordingly, we have enumerated the developed biosensors for early detection of pediatric cancer or related biomarkers. This review offers a restructured platform for ongoing research in pediatric cancer diagnostics that can contribute to the development of rapid biosensing techniques for early-stage diagnosis, monitoring, and treatment of children with cancer and reduce the mortality rate.

Biotin-functionalized nanoparticles: an overview of recent trends in cancer detection

“…44,53–55 The distinctive binding characteristics of avidin–biotin methodologies to diverse biomaterials, such as DNA and RNA, NPs, antibodies, and aptamers. 49,54,55 Several biotinylated techniques can identify Hodgkin lymphoma, 56 breast, 57 lung, 58 prostate, 59 and cervical 60 cancer cells.…”

Application of Biosensors in Detecting Breast Cancer Metastasis

“…The structure of biosensors typically comprises several key components, as seen from Figure 2. Recognition Element [53,54]: This is the core component of biosensors used to selectively identify target biomolecules. The recognition element is typically a biomolecule such as antibodies, enzymes, nucleic acid probes, or cell receptors, possessing specificity for binding to the target molecule.…”

Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis

“…To date, biosensor development is becoming a prevalent approach for effectual point-of-care testing with high-level accuracy, reproducibility, reliability, stability, affordability, and disposability. [54,55] In particular, biosensor research is deemed as a required field to detect the toxins and cancer cells in the blood, and numerous researchers have developed biosensors to sense the different types of biomarkers responsible for cancer and other diseases. [56] The recent development of biosensors has focused on five types of advanced sensors using different transducer elements to sense biomolecules, i.e., electrochemical, [57,58] fluorescence, [59] electrochemiluminescence (ECL), [60] surface plasmon resonance (SPR), [61] and quartz crystal microbalance (QCM), [62] which in turn produce measurable current, light, and frequency signals, enabling monitoring of analytes in extremely low concentrations (Figure 1).…”